Synthesized boron compounds: Neurotoxic and oxidative effects in an in vitro model of Alzheimer's disease
Küçük Resim Yok
Tarih
2025
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Sage Publications Ltd
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Objective Alzheimer's disease (AD) is characterized by amyloid-beta (A beta 1-42) aggregation, oxidative stress, and neuronal loss, necessitating novel therapeutic agents to mitigate these pathological hallmarks. Method This study investigates the neuroprotective and antioxidant properties of newly synthesized borenium (compounds 1-4) and borinium (compounds 5-8) derivatives in an in vitro AD model using differentiated SH-SY5Y neuroblastoma cells exposed to A beta 1-42. Furthermore, automated Total Antioxidant Capacity assays were conducted using commercially available kits on culture media collected from cell cultures following 24 h of incubation. 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide and lactate dehydrogenase tests were done to determine the cytotoxicity of boron compounds after application to the exposed cell lines of A beta 1-42. Results It was determined that the boron compounds applied to the cell lines at different concentrations did not show any neurotoxic effect at a concentration of 50 mu M in 24 h of incubation. All boron compounds were determined to have antioxidant properties. It was found that the borinium compounds are much more neuroprotective than the borenium. Conclusion These findings highlight the therapeutic potential of borenium and borinium compounds as neuroprotective and antioxidant agents for AD, warranting further mechanistic and in vivo studies.
Açıklama
Anahtar Kelimeler
A Beta 1-42, Alzheimer'S Disease, Boron Compounds, Neuroprotective, Oxidative Effect
Kaynak
Science Progress
WoS Q Değeri
Q2
Scopus Q Değeri
Q1
Cilt
108
Sayı
4












